Denver Investment Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-71,628
Closed -$628K 445
2017
Q3
$628K Sell
71,628
-10,565
-13% -$85.9K 0.03% 286
2017
Q2
$685K Buy
82,193
+5,115
+7% +$41.7K 0.03% 273
2017
Q1
$708K Buy
77,078
+15,563
+25% +$127K 0.03% 279
2016
Q4
$476K Buy
61,515
+47,192
+329% +$353K 0.02% 347
2016
Q3
$109K Sell
14,323
-420
-3% -$2.38K ﹤0.01% 419
2016
Q2
$74K Sell
14,743
-2,560
-15% -$13.7K ﹤0.01% 439
2016
Q1
$93K Buy
17,303
+1,204
+7% +$7.12K ﹤0.01% 442
2015
Q4
$116K Buy
16,099
+240
+2% +$1.62K 0.01% 478
2015
Q3
$74K Buy
+15,859
New +$151K ﹤0.01% 519

Other funds holding VCYT

Denver Investment Advisors's VCYT Position: Q4 2017 in Review

Denver Investment Advisors sold out of Veracyte (VCYT) in Q4 2017, closing a stake of 71,628 shares — an estimated $628K sold.

Denver Investment Advisors first reported a position in VCYT in Q3 2015 and held it in 9 quarters. The position peaked at $708K in Q1 2017. 79 funds tracked by Wall St. Rank hold VCYT as of Q4 2017.

  • Denver Investment Advisors reported no remaining Veracyte position as of Q4 2017 after selling out during the quarter.
  • Denver Investment Advisors sold 71,628 Veracyte shares in Q4 2017, an estimated $628K.
  • Denver Investment Advisors first reported a position in Veracyte in Q3 2015 and held it in 9 quarters.
  • Denver Investment Advisors's Veracyte position peaked at $708K in Q1 2017.
  • 79 funds tracked by Wall St. Rank held Veracyte as of Q4 2017.

Based on Denver Investment Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.